Episode
Mass loss of trust
- Podcast
- Dr. John Campbell
- Published
- Jul 11, 2026
- Duration seconds
- 1946
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/VG6527218674.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/mass-loss-of-trust/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/dr-john-campbell-7851784/mass-loss-of-trust.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Is there a crisis of trust? https://ourworldindata.org/coronavirus John's free textbooks Download my two comprehensive but free educational text books or make a donation to the campbellteaching project using this link: http://159.69.48.3Russia https://www.youtube.com/watch?v=ijgNJpUes4Y https://www.dailymail.co.uk/news/article-10084049/Video-showing-Putin-coughing-meeting-emerges-forced-deny-having-Covid-19.html Infections, + 29,409 Deaths, + 973 = 217,000 Delta variant Vaccine hesitancy First dose, 33% Rolled out before trials Problem is not that bad Government had won the war on covid-19 Mr. Putin pulls out of G20 meeting due to 'diary clash' Two doses of Sputnik V ITU, 8,000 patients Patients becoming critical in 3 to 4 days Vaccination passports cost 70 euros Widespread public misconceptions Hygiene rules hardly followed Limited restrictions Limited mask wearing Official information not believed Indian summer just now Moscow may well cope New infectious disease hospital Regions, hospitals already full Molnupiravir, Merck, awaiting EMU US government at $700 (£515) per course Analysts at Harvard School of Public Health and King's College Hospital in London have found it costs just $17.74 (£13) to produce. Despite this, Merck and Ridgeback could earn $7 billion in profits by the end of the year. https://news.sky.com/story/covid-news-uk-latest-live-experts-discover-why-people-get-covid-toes-as-wales-introduces-vaccine-passports-12425651 https://www.fiercepharma.com/pharma/merck-molnupiravir-blockbuster-covid-19-pandemic-endemic-oral-antivirals-market That’s about $700 per course. Merck said it expects to make 10 million courses of the drug by the end of 2021, meaning $7 billion in revenue BBC Media Action £1,569,000 in 2019 - 2020 https://www.bbc.co.uk/mediaaction/abou…